Abbreviations & Acronyms CAVI = cardio-ankle vascular index FVC = frequency volume chart LUTS = lower urinary tract symptoms MFR = maximum flow rate OAB = overactive bladder OABSS = overactive bladder symptom score PVR = post-void residual urine volume RARP = robot-assisted laparoscopic radical prostatectomy UFM = uroflowmetry UUI = urgency urinary incontinence Objectives: To assess whether atherosclerosis is involved in the development of overactive bladder and the function of lower urinary tract after robot-assisted radical prostatectomy. Methods: The present cohort consisted of 80 consecutive participants. The preoperative cardio-ankle vascular index was used to evaluate the presence of atherosclerosis. The present cohort was split into two groups, the atherosclerotic group, whose cardio-ankle vascular index was ≥9.0, and the control group, whose index was <9.0. The overactive bladder symptom score and lower urinary tract function were compared for 12 months after surgery. Results: The total score of the questionnaire was significantly higher at 6 and 9 months after surgery in the atherosclerosis group (P = 0.04, P = 0.03, respectively). Both the urgency and urgency incontinence subscores of the questionnaire showed a parallel tendency to that of the total score after surgery. At 3 months after surgery, there was a significant increase in the prevalence of de novo overactive bladder in the atherosclerosis group (P = 0.04). At 9 and 12 months after surgery, there was a significant decrease of voided volume in the atherosclerotic group (P < 0.01, P = 0.04, respectively). Conclusions: Atherosclerosis delays the improvement in both overactive bladder symptoms and storage function postoperatively, and it is involved in the transient increase in the prevalence of de novo overactive bladder. Atherosclerosis might be a predictor of the development of overactive bladder after robot-assisted radical prostatectomy.
Introduction
Transient lower urinary tract dysfunction is likely to occur after radical prostatectomy, even after RARP, due to the temporary damage to the bladder and urethra from the operative procedure. Thus, many patients temporarily suffer not only storage but also voiding symptoms for a certain time after radical prostatectomy. 1 OAB is a symptom syndrome defined as urgency, with or without urgency incontinence, usually with frequency and nocturia. 2 Although attention has been paid to stress urinary incontinence as a familiar complication after radical prostatectomy, OAB symptoms tend to be neglected by physicians, even though 10-20% of patients after radical prostatectomy develop de novo OAB. 3, 4 Furthermore, OAB symptoms are reported to be more challenging than stress urinary incontinence. [5] [6] [7] In addition, although post-prostatectomy stress urinary incontinence improves slowly, 8 a long time is usually required for OAB symptoms to improve. 3 Therefore, elucidating the causes of OAB symptoms after radical prostatectomy seems important.
Atherosclerosis has been considered to be one of the important factors, and a possible underlying mechanism of OAB and LUTS in men and women. 9 Thus, the involvement of atherosclerosis in the etiology of OAB has recently attracted attention. Consequently, we presumed that atherosclerosis is involved in not only the emergence of OAB symptoms after RARP, but also the chronological changes of lower urinary tract dysfunction after RARP, and that the seriousness of atherosclerosis serves as a marker for predicting protracted OAB symptoms.
In the present study, the relationships between the presence or absence of atherosclerosis and OAB symptoms after RARP were examined using perioperative parameters to clarify whether atherosclerosis is involved in the etiology of OAB after RARP.
Methods
The participants in the present prospective, clinical cohort, observational study were 80 consecutive patients who underwent RARP at Fukushima Medical University Hospital, Fukushima, Japan, between February 2013 and January 2014. RARP was carried out using the four-arm Da Vinci Si surgical system (Intuitive Surgical, Sunnyvale, CA, USA) with a combination of anterior and posterior intraperitoneal approaches. In all cases, the anastomosis between the urethra and bladder started with the Rocco technique for posterior reconstruction of Denonvilliers' fascia, 10 followed by Van Velthoven's stitch 11 using a running, double-armed, barbed 3-0 polyglyconate suture (V-LOC; Covidien, Mansfield, MA, USA).
In the present study, although the present cohort was identical to that of the previous study, 12 quite a different analysis was carried out to clarify the effect of atherosclerosis on the development of OAB. In addition, the observation period was between February 2013 and January 2015; it was, therefore, 6 months longer than that of the previous study. 12 The exclusion criteria were as follows. Baseline lower urinary tract abnormalities, such as neurogenic bladder, were excluded in the present cohort. Patients who underwent salvage radiotherapy and androgen deprivation therapy, and who took medications that affected lower urinary tract function were also excluded from the present study. Informed consent was obtained from all patients before the study after explaining its purpose and methods. The study protocols were approved by the ethics committee at our institution.
Evaluation of the severity of atherosclerosis
The CAVI before RARP was used to evaluate the severity of atherosclerosis. 13 The CAVI was measured with a VaSera VS-1000 (Fukuda Denshi, Tokyo, Japan) by the methods described previously. 12, 14 According to the manufacturer's recommendations, a CAVI <8 was considered normal; 8≤ CAVI <9 was considered borderline; and a CAVI ≥9 was considered abnormal. 15 Patients with a CAVI ≥9 have been reported to have significantly higher mean and maximum intima-media thicknesses. 16 Therefore, a CAVI of 9.0 was used as the cutoff value for atherosclerosis in the present study.
Assessment of overactive bladder and lower urinary tract function after RARP
Symptoms of OAB were assessed using the OABSS. The OABSS, which was developed and validated in the Japanese population, was used in the present study. 17 The OABSS was composed of four questions; that is, question 1 (daytime frequency), question 2 (night-time frequency), question 3 (urgency) and question 4 (UUI). The OABSS total score is the sum of the scores of each item (questions 1-4). Scores range from 0 to 15, with greater scores indicating increasing symptom severity. A patient was defined as having OAB when the score for question 3 was >2 points and the sum of the OABSS scores was >3 points. Furthermore, in the present study, de novo OAB was defined as newly developed OAB after RARP.
UFM and PVR, as determined by ultrasonography, were used to evaluate lower urinary tract function after RARP. Furthermore, 3-day FVCs were used to evaluate voiding volumes and frequency. OAB symptoms and lower urinary tract function were evaluated just before RARP, and then again at 1, 3, 6, 9 and 12 months after RARP.
In the present study, the cohort was split into two groups, the atherosclerotic group, with a CAVI ≥9.0, and the control group, with a CAVI <9.0. Subjective items derived from the OABSS, and objective items derived from UFM, PVR and FVCs were measured and compared between the two groups. In addition, whether atherosclerosis induced de novo OAB after RARP was investigated.
Statistical analysis
All values are presented as the mean AE SD. Student's t-test was used to test for significant differences in binary variables between two groups. To identify the independent factors correlated with OAB symptoms after RARP, multivariate regression analysis was carried out. A P-value <0.05 was chosen as the criterion for significance. All statistical analyses were carried out using SPSS version 21 (IBM, Armonk, NY, USA).
Results
The present cohort consisted of 80 patients. These patients were categorized into the atherosclerosis group (n = 50) and the control group (n = 30; Table 1 ). The background of the patients and their perioperative parameters were presented in our previous report. 12 The mean age of the present cohort was significantly older in the atherosclerotic group than in the control group (P = 0.005; Table 1 ). There were significantly more patients with a history of dyslipidemia treatment (P = 0.021) and who underwent a nerve-sparing procedure during RARP (P = 0044) in the atherosclerosis group than in the control group. No significant differences in the preoperative total scores of OABSS and no significant differences in preoperative subscores of OABSS were observed between the two groups (Table 1 ). In addition, no obvious differences in the preoperative MFR and preoperative voided volume on UFM and preoperative PVR were observed between the two groups (Table 1) . Therefore, the patients' background characteristics, other than age and history of dyslipidemia treatment, were not significantly different between the atherosclerosis group and the control group (Table 1) . Furthermore, perioperative parameters, except the nerve-sparing procedure, were not significantly different between the atherosclerosis group and the control group (Table 1) .
Course of OAB symptoms and lower urinary tract function in atherosclerotic patients after RARP At 1 month after RARP, the OABSS total score and the OABSS subscores increased transiently in both groups, but they improved gradually in the two groups (Fig. 1) . The OABSS total score was significantly higher at 6 and 9 months after RARP (P = 0.04, P = 0.03, respectively) in the atherosclerosis group, but no significant difference was observed in the two groups at 12 months after RARP (Fig. 1 ). There was a parallel tendency in the OABSS subscores. Namely, scores for question 3 (urgency) and question 4 (UUI) were significantly higher both at 6 and 9 months after RARP in the atherosclerosis group. However, the scores for question 3 (urgency) and question 4 (UUI) were not significantly different in both groups at 12 months after RARP (Fig. 1) .
On UFM, at 1 month after RARP, there were decreases in the MFR, and the voided volume decreased in both groups. Although there was gradual improvement in both groups, MFR was constantly less postoperatively in the atherosclerosis group than in the control group, and the differences were significant at 6 and 9 months after RARP (P = 0.02 and P = 0.04, respectively; Fig. 2a ). Voided volume was significantly less at 9 and 12 months postoperatively in the atherosclerotic group than in the control group (P < 0.01 and P = 0.04, respectively; Fig. 2 ). There was a decrease in PVR postoperatively in both groups, but there were no significant differences between the two groups. On the FVCs, significant differences in mean voided volume, total voided volume and total micturition frequency were not observed during the observation period between the two groups (Fig. 3) .
Confirmation of the factors associated with OAB symptoms after RARP
Multivariate regression analyses were carried out to determine which factors were correlated with the occurrence of OAB symptoms at 6 months after RARP, because significant differences were observed in the OABSS total score and the subscores of question 3 and question 4 at this evaluation point ( Table 2 ). The OABSS total score and the subscores of question 3 and question 4 were chosen as dependent variables. Age, CAVI, preoperative OABSS total score, operative time, estimated blood loss, nerve-sparing procedure and prostate weight were chosen as independent variables (Table 2) . These statistical analyses showed that the CAVI and the preoperative OABSS total score were associated with the OABSS total score and the subscores of question 3 and question 4 after RARP (Table 2 ). However, age was not associated with the OABSS total score and the subscores of question 3 and question 4 after RARP (Table 2) .
De novo OAB in atherosclerotic patients after RARP
To determine the prevalence of de novo OAB after RARP, 11 patients in the atherosclerosis group and four patients in the control group, who had OAB before RARP, were excluded from this analysis. The prevalence of de novo OAB was significantly higher in the atherosclerosis group 3 months after RARP (P = 0.04; Fig. 4) . The OABSS subscore analyses in de novo OAB patients showed that scores for both question 3 (urgency) and question 4 (UUI) were significantly higher at 3 months (question 3, P = 0.04; question 4, P = 0.01) and 6 months (question 3, P = 0.04; question 4, P = 0.01) after RARP in the atherosclerosis group (Fig. 5 ).
Discussion
The focus of attention has currently shifted to the effect of atherosclerosis on the incidence of LUTS. 18, 19 We have already shown the relationship between atherosclerosis and lower urinary tract symptom and/or dysfunction, both in animal studies and in clinical studies. 12, 20, 21 In the animal studies, our group showed that atherosclerosis causes chronic bladder ischemia leading to detrusor overactivity. 20, 21 Also, in the clinical study, we showed that atherosclerosis interfered with the improvement in not only voiding symptoms, but also voiding function after RARP, leading to deterioration of quality of life in the early postoperative period. 12 The differences between our previous study and the present study were that our previous study investigated the association between atherosclerosis and LUTS evaluated by the International Prostate Symptom Score over a 6-month shorter observational period than that of the present study.
Expanding beyond our basic and clinical studies mentioned above, in the present study, whether atherosclerosis is associated with OAB symptoms and the emergence of de novo OAB after RARP was investigated, using the CAVI to evaluate the degree of atherosclerosis. The present results showed that recovery from the OAB symptoms with urgency and/or urgency incontinence after RARP was significantly delayed in the atherosclerosis group compared with that in the control group. In addition, improvement from the decrease of the voided volume per micturition, which was evaluated by UFM, was significantly delayed after RARP in the atherosclerosis group. Thus, recoveries of both the storage symptoms and storage function were significantly delayed after RARP in the atherosclerosis group.
In contrast, in the present study, there was no significant difference in the volume of urinary incontinence evaluated by the 1-h pad test between the atherosclerosis group and the control group (data not shown). Although the 1-h pad test included the provocation maneuver "washing hands by running water," which could induce urgency incontinence, 1, 22, 23 the reason why a significant difference between the two groups was not observed was that stress urinary incontinence occurs mainly due to weakened function of the external urethral sphincter after RARP. 24 Therefore, UUI might be masked by a copious amount of stress urinary incontinence during a 1-h pad test.
One of the possible reasons for an increase in prolonged OAB symptoms due to atherosclerosis after RARP is as follows. The internal iliac artery provides the blood supply to the lower urinary tract including the bladder, and obstructive changes in the internal iliac arteries due to atherosclerosis would decrease the blood flow to the bladder. 25 In chronic ischemia of the bladder due to atherosclerosis, repetitive ischemia/reperfusion episodes during the voiding and storage phases could increase oxidative stress and accelerate the inflammatory changes in the bladder, with release of agents, such as prostaglandins and nerve growth factor, which are important for the generation of detrusor overactivity. 26 In a situation in which detrusor overactivity could easily occur, temporary surgical damage to the bladder after radical prostatectomy could also accelerate the denervation supersensitivity of the detrusor muscle. 27 As a consequence, less improvement in OAB symptoms after radical prostatectomy could occur in the process of improvement in LUTS, along with the aggravation of storage function. However, the differences in OAB symptoms between the control group and atherosclerosis group disappeared at 12 months. The possible reason is described below. Kadono et al. showed that lower urinary tract function evaluated by urodynamic studies improved with time after RARP, and it had almost improved to the preoperative level at 12 months after RARP. 24 Therefore, although urodynamic studies were not carried out in the present study, owing to the gradual improvement in lower urinary tract function, the difference in OAB induced by atherosclerosis might have disappeared at 12 months after RARP.
Although the prevalence of de novo OAB reached a peak at 1 month after RARP and decreased gradually with time after RARP, not only in the atherosclerosis group, but also in the control group, it was always greater in the atherosclerosis group than in the control group. Especially at 3 months after RARP, the prevalence of de novo OAB was significantly higher in the atherosclerotic group. Therefore, atherosclerosis might also be associated with the occurrence of de novo OAB. Hosier et al. reported that adjuvant or salvage radiation therapy after radical prostatectomy increased the likelihood of developing de novo OAB. 4 The reason for developing de novo OAB after radiation is thought to be due to radiation damage to the lower urinary tract owing to the endarteritis, leading to a decrease in blood supply and a decrease in nutrient delivery to the detrusor muscle. 28 Because atherosclerosis could also decrease the blood supply to the detrusor muscle, there might be a possibility of an additional increase in the prevalence of de novo OAB after adjuvant salvage radiation therapy in patients with atherosclerosis. Thus, when salvage or adjuvant radiation is carried out after RARP, it might be important to inform patients with atherosclerosis of the possibility of developing de novo OAB and obtain their informed consent.
In our clinical study regarding postoperative LUTS and lower urinary tract function, we showed that atherosclerosis delayed the improvement in not only the voiding symptoms, but also voiding function, after RARP, decreasing patients' quality of life in the early postoperative period. 12 This is the first study to establish the relationship between the severity of atherosclerosis and late improvement in OAB symptoms after RARP with a longer observational period than in the previous study, in which the observational period was 6 months. 12 Taking into consideration the present study and the above-mentioned previous study, atherosclerosis might have a harmful effect on the improvement in both LUTS and lower urinary tract function after RARP.
Several methodological limitations must be taken into consideration when considering the results of the present study. First, this study had a small sample size, because the present study was carried out in only a single institution. Statistical power to identify relationships between atherosclerosis and OAB symptoms might thus have been insufficient in the present study. Second, the impact of increasing age on LUTS and lower urinary tract dysfunction could not be sufficiently excluded in this study. However, age was not significantly associated with OAB symptoms in the multivariate analyses in the present study. Thus, to completely exclude the effect of age on OAB symptoms after RARP, an age-adjusted, multicenter, clinical trial with a large sample size would be required.
In conclusion, atherosclerosis was associated with less improvement in the decrease in voided volume after RARP, with delayed improvement in OAB symptoms. Furthermore, atherosclerosis led to a transient increase in the prevalence of de novo OAB after RARP. Thus, atherosclerosis is a possible predictor of delayed improvement in OAB symptoms and of a transient increase of de novo OAB after RARP.
